|
(11) Diet Modification to Augment Radiation for Breast Cancer Brain Metastases
|
1R01CA227479-01
|
$351,726
|
|
SIMONE, NICOLE
|
THOMAS JEFFERSON UNIVERSITY
|
|
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy
|
1R01CA227466-01
|
$699,062
|
|
ZIV, ELAD
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(8) Genomic determinants of the T-cell regulome in immune checkpoint blockade
|
1R01CA227505-01
|
$620,860
|
|
KIRCHHOFF, TOMAS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
(8) Mechanisms of autoimmune endocrine diseases in patients receiving checkpoint inhibitors
|
1R01CA227473-01
|
$580,767
|
|
HEROLD, KEVAN
|
YALE UNIVERSITY
|
|
(PQ 12) Targeting SMPDL3b to Prevent Radiation-Induced Nephrotoxicity
|
1R01CA227493-01
|
$427,990
|
|
MARPLES, BRIAN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
(PQ1) Epigenetic effects of the premalignant field
|
5R01CA208620-03
|
$415,599
|
|
TERADA, LANCE
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome
|
1R01CA219896-01A1
|
$429,943
|
|
WARGO, JENNIFER
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQ10) Harnessing the human gut microbiome to predict chemotherapy outcomes
|
1R21CA227232-01
|
$208,746
|
|
TURNBAUGH, PETER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQ10) The impact of the gut microbiome on the anti-tumor effects of radiotherapy
|
1R01CA219871-01A1
|
$451,326
|
|
FACCIABENE, ANDREA
|
UNIVERSITY OF PENNSYLVANIA
|
|
(PQ10) Understanding How Commensal Microbiota Affect the Anti-tumor Action of Radiotherapy
|
1R21CA227528-01
|
$176,175
|
|
WEICHSELBAUM, RALPH
|
UNIVERSITY OF CHICAGO
|
|
(PQ12) Peroxisome proliferator-activated receptor alpha agonists as potential treatment for chemotherapy-induced peripheral neuropathy
|
1R01CA219637-01A1
|
$281,441
|
|
DAMAJ, M IMAD
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
(PQ3) A functional genomic approach to identification and interpretation of germline-tumor genetic interactions
|
1R01CA227237-01
|
$686,519
|
|
GUSEV, ALEXANDER
|
DANA-FARBER CANCER INST
|
|
(PQ4) Anal HPV infection and anal HSIL among HIV-infected MSM aged 50+ years
|
5R01CA206477-03
|
$791,933
|
|
PALEFSKY, JOEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
|
5R21CA217137-02
|
$196,947
|
|
EL-MALLAWANY, NADER
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ5) Relevance of VDAC2 heterogeneity for hepatic tumor growth and targeting
|
1R01CA216254-01A1
|
$413,916
|
|
HAJNOCZKY, GYORGY
|
THOMAS JEFFERSON UNIVERSITY
|
|
(PQ6) Roles of circadian rhythms in tumor development
|
1R21CA227379-01
|
$208,800
|
|
HONG, CHRISTIAN
|
UNIVERSITY OF CINCINNATI
|
|
(PQ6): Is Adrenergic Stress-induced Immune Suppression at the Crossroads of Circadian Rhythm Disruption and Cancer?
|
1R21CA227375-01
|
$224,199
|
|
REPASKY, ELIZABETH
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
(PQ7) Quantitative in vivo optical imaging of tumor heterogeneity
|
5R01CA205101-03
|
$384,612
|
|
SKALA, MELISSA
|
MORGRIDGE INSTITUTE FOR RESEARCH, INC.
|
|
(PQA1) Aspirin and Inflammation: Mutations, Genes, Pathways and Prevention
|
1R01CA179949-01
|
$474,940
|
$474,940
|
REID, BRIAN
|
FRED HUTCHINSON CAN RES CTR
|
|
(PQA4) Point-of-Care Test of Exposure to Hepatocellular Carcinoma Risk by V-Chip
|
1R01CA180083-01
|
$534,498
|
$176,384
|
Qin, Lidong
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
|
(PQB4) Age-cancer interplay of genome and epi-genome in human lung
|
1R01CA180126-01
|
$701,255
|
$350,628
|
VIJG, JAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
(PQC3) Ethnicity-determined immune response and DCIS outcome
|
5R01CA194600-04
|
$179,518
|
$179,518
|
BADVE, SUNIL
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer
|
5R01CA201250-03
|
$695,342
|
|
LARSON, STEVEN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
15-LOX-1 Regulation of Resolving Generation to Modulate Colon Cancer
|
5R01CA195686-03
|
$366,000
|
|
SHUREIQI, IMAD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
4E-BP Mimetics as Chemical Probes for Studying Translational Control in Cancer
|
5R01CA202018-03
|
$354,563
|
|
GARNER, AMANDA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
A blood test to identify prostate cancer patients at risk for visceral metastasis
|
5R01CA218356-02
|
$601,750
|
|
POSADAS, EDWIN
|
CEDARS-SINAI MEDICAL CENTER
|
|
A cohort mortality study with a nested case-control study of lung cancer and dies
|
ZIA CP010120-02091
|
$351,752
|
$158,289
|
Silverman, Debra
|
DCEG (NCI)
|
|
A cohort study among workers exposed to benzene in China
|
ZIA CP010120-02060
|
$425,790
|
$191,605
|
Rothman, Nat
|
DCEG (NCI)
|
|
A Cohort Study of Sessile Serrated Polyps and Subsequent Colorectal Neoplasia
|
1R01CA168338-01A1
|
$668,122
|
$668,122
|
Newcomb, Polly
|
FRED HUTCHINSON CAN RES CTR
|
|
A comprehensive approach to breast cancer susceptibility across the risk spectrum
|
5R01CA155767-03
|
$497,212
|
$497,212
|
Goldgar, David
|
UNIVERSITY OF UTAH
|
|
A CROSS-SECTIONAL STUDY OF OCCUPATIONAL EXPOSURE TO TRICHLOROETHYLENE, CHROMOSOMA
|
ZIA CP010121-10363
|
$39,667
|
$17,850
|
Lan, Qing
|
DCEG (NCI)
|
|
A Drug Delivery Strategy for Targeted Therapy of Chronic Lymphocytic Leukemia
|
2R01CA174844-04
|
$575,010
|
|
RADER, CHRISTOPH
|
SCRIPPS FLORIDA
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5UM1CA164974-02
|
$2,686,982
|
$2,686,982
|
Rosenberg, Lynn
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A genomewide study of lung cancer in never smokers
|
5R01CA149462-04
|
$364,638
|
$364,638
|
Gorlova, Olga
|
UT MD ANDERSON CANCER CTR
|
|
A Highly Multiplexed Gene Expression Platform for Fixed Tissue Specimens
|
5R21CA202875-03
|
$202,500
|
|
LARMAN, HARRY
|
JOHNS HOPKINS UNIVERSITY
|
|
A Hospital-based Case-Control Study of Non-smoking Women in Xuan Wei and Fu Yuan,
|
ZIA CP010121-10349
|
$81,747
|
$36,786
|
Lan, Qing
|
DCEG (NCI)
|
|
A multi-center international hospital-based case-control study of lymphoma in Asi
|
ZIA CP010136-10512
|
$1,147,653
|
$516,444
|
Lan, Qing
|
DCEG (NCI)
|
|
A Naturalistic Nationwide Randomized Study of e-Cigarette Uptake and Consequences
|
5R01CA210625-02
|
$542,711
|
|
CARPENTER, MATTHEW
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
A Network Analytic Approach to Modeling Variation in Prostate Cancer Care
|
5K07CA151910-03
|
$156,570
|
$156,570
|
Pollack, Craig
|
JOHNS HOPKINS UNIVERSITY
|
|
A network-based approach for personalized treatment of Multiple Myeloma
|
5R21CA209875-02
|
$184,331
|
|
PAREKH, SAMIR
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
A new approach to identify rare genetic variants influencing melanoma risk
|
4R03CA156624-02
|
$54,144
|
$27,072
|
Lesueur, Fabienne
|
INTERNATIONAL AGENCY FOR RES ON CANCER
|
|
A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis
|
3R01CA190776-04S1
|
$116,456
|
|
EL-SERAG, HASHEM
|
BAYLOR COLLEGE OF MEDICINE
|
|
A New Mechanism for Castration Resistant Prostate Cancer
|
5R01CA166894-06
|
$368,984
|
|
SUN, ZIJIE
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A Novel Druggable Epigenetic Vulnerability Pathway in HCC
|
1R01CA218008-01A1
|
$599,752
|
|
GREEN, MICHAEL
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
A novel N-Ras pathway driving DCIS to basal-like breast cancer
|
1R21CA226567-01
|
$212,055
|
|
CHANG, ERIC
|
BAYLOR COLLEGE OF MEDICINE
|
|
A novel T-cell subset able to kill relapsed cancers
|
5R01CA200539-03
|
$362,569
|
|
YI, QING
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
A novel time-resolved fluorescence-based high-throughput screening technology for discovering allosteric kinase inhibitors
|
5R21CA217695-02
|
$231,000
|
|
LEVINSON, NICHOLAS
|
UNIVERSITY OF MINNESOTA
|
|
A Novel Values-based Intervention to Increase Endocrine Therapy Adherence among Breast Cancer Survivors
|
1R21CA218723-01A1
|
$207,450
|
|
ARCH, JOANNA
|
UNIVERSITY OF COLORADO
|
|
A partnership to enable clinical ctDNA testing for breast cancer recurrence
|
5R01CA204253-03
|
$472,123
|
|
VARLEY, KATHERINE
|
UNIVERSITY OF UTAH
|
|
A Phase III Randomized Trial Targeting Behavioral Symptoms in Younger Breast Cancer Survivors
|
5R01CA200977-03
|
$639,777
|
|
GANZ, PATRICIA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
Total relevant funding to Biochemical Epidemiology for this search: $249,399,553
|